Mode
Text Size
Log in / Sign up

Obstructive Sleep Apnea Affects Nearly Half of Cystic Fibrosis PatientsNearly half of people with cystic fibrosis have sleep apnea

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Nearly half of CF patients have OSAHS, which is linked to worse lung function and oxygen levels, supporting earlier screening.

A comprehensive meta-analysis reveals that obstructive sleep apnea-hypopnea syndrome (OSAHS) is highly prevalent in individuals with cystic fibrosis (CF), affecting approximately 48% of patients. The analysis, which included multiple studies, found significant heterogeneity (I² = 96.5%) in prevalence estimates, suggesting variability across populations.

In pediatric CF patients, the mean apnea-hypopnea index (AHI) was 3.47, while in adults it was 6.19, indicating more severe sleep-disordered breathing in older patients. Compared to OSAHS-negative patients, those with OSAHS had higher AHI and arousal indices, lower oxygen saturation, and worse pulmonary function.

These findings underscore the importance of screening for OSAHS in CF patients, as the condition is associated with poorer clinical outcomes. The authors advocate for earlier polysomnography to facilitate timely intervention and potentially improve respiratory function and quality of life.

Despite the high heterogeneity, the results consistently point to a link between OSAHS and worse CF outcomes. Further research is needed to clarify the causal relationship and to develop optimal screening protocols.

How this fits prior evidence

This meta-analysis extends prior coverage on cystic fibrosis by identifying a high prevalence of OSAHS (48%) in CF patients, a comorbidity not addressed in earlier items on muscle ultrasound, antimycobacterial therapy, CFTR modulators, or NAC. The finding of worse pulmonary function in OSAHS-positive patients aligns with the general understanding that comorbidities worsen CF outcomes, though causality cannot be inferred.

Living with cystic fibrosis is already a significant challenge for the lungs. New data shows that many of these patients also face another hurdle: obstructive sleep apnea (OSAHS). This is a condition where breathing repeatedly stops or becomes shallow during sleep. The study found that about 48% of people with cystic fibrosis have this sleep disorder.

For those who do have sleep apnea, the impact on their health is measurable. These patients showed lower oxygen levels and worse lung function compared to those without the condition. They also had higher arousal indices, meaning they woke up more frequently during the night. While the data shows a high amount of variation in how often this occurs across different groups, the link between sleep apnea and poorer breathing remains clear.

Because of these findings, experts suggest that doctors should screen for sleep issues earlier. By using sleep tests sooner, medical teams can step in with treatments to help patients breathe better at night. If you or a loved one has cystic fibrosis, talk to your doctor about whether a sleep study is right for you.

What this means for you:
Nearly half of people with cystic fibrosis have sleep apnea, which can lead to lower oxygen and worse lung function.

Common questions

How common is sleep apnea in people with cystic fibrosis?

The study found that the prevalence of obstructive sleep apnea (OSAHS) in patients with cystic fibrosis is 48%. This means nearly half of those living with cystic fibrosis also experience this breathing issue during sleep.

How does sleep apnea affect someone with cystic fibrosis?

Patients with sleep apnea showed lower oxygen saturation and worse pulmonary function compared to those without it. They also had a higher arousal index, meaning they were disturbed more often during the night.

What are the specific lung measurements for these patients?

The study measured the apnea-hypopnea index (AHI), which tracks breathing pauses. The average AHI was 3.47 for pediatric patients and 6.19 for adult patients with cystic fibrosis.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
BACKGROUND: This research aimed to evaluate the prevalence of obstructive sleep apnea-hypopnea syndrome (OSAHS) in individuals with cystic fibrosis (CF) and to examine its relationship with sleep monitoring parameters and pulmonary function. METHODS: Five databases (EMBASE, PubMed, Web of Science, CNKI, and Cochrane Library) were searched for publications on the prevalence of OSAHS in CF. Two independent researchers assessed study quality using the Joanna Briggs Institute tool. Weighted mean differences were calculated for continuous variables, and the model choice (random vs fixed effects) was determined by whether I2 exceeded 50%. RESULTS: Fourteen studies were included: 11 in the prevalence meta-analysis and 13 in the mean apnea-hypopnea index (AHI) analysis. Six studies compared sleep and pulmonary parameters between CF patients with and without OSAHS. The pooled prevalence of OSAHS in CF was 48% (I2 = 96.5%), slightly higher in pediatric than adult patients. The mean AHI was 3.47 in pediatric patients with CF and 6.19 in adult individuals with CF. Compared to OSAHS-negative patients, OSAHS-positive patients exhibited higher AHI and arousal index, lower mean and minimum oxygen saturation, and worse pulmonary function. CONCLUSION: There is a significant prevalence of OSAHS among patients with CF, notably within the pediatric demographic. Patients with CF generally present with elevated AHI values and poorer pulmonary function in those with concurrent OSAHS. The findings advocate for earlier polysomnography screening in patients with CF to facilitate timely intervention.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.